Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.

Haubrich RH, Riddler SA, DiRienzo AG, Komarow L, Powderly WG, Klingman K, Garren KW, Butcher DL, Rooney JF, Haas DW, Mellors JW, Havlir DV, AIDS Clinical Trials Group (ACTG) A5142 Study Team
AIDS. 2009 23 (9): 1109-18

PMID: 19417580 · PMCID: PMC2739977 · DOI:10.1097/QAD.0b013e32832b4377

MeSH Terms (16)

Absorptiometry, Photon Adult Alkynes Benzoxazines Cyclopropanes Female HIV-1 HIV-Associated Lipodystrophy Syndrome HIV Infections HIV Protease Inhibitors Humans Lipid Metabolism Lopinavir Male Pyrimidinones Ritonavir

Connections (1)

This publication is referenced by other Labnodes entities: